Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chain Bridge Capital is a boutique investment and advisory firm primarily focused on the life sciences, healthcare, and technology sectors. The firm provides strategic advisory services, including capital raising, mergers and acquisitions (M&A) support, and corporate development for emerging growth companies. While it operates within the healthcare ecosystem, it does not develop its own therapeutic pipeline, instead facilitating the growth and financing of biotech and medtech entities. The firm is notably associated with the formation of Chain Bridge I, a special purpose acquisition company (SPAC) intended to identify and merge with high-growth targets in the healthcare or technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chain Bridge Capital.